Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2009 · 10 citations · 11 references
EngineeringBiomedical EngineeringCardiologyBiosensorsNanomaterialsNanotechnologyCardiac BiomarkersMicrofluidic BiosensorsNanomaterial-based BiosensorsOptical BiosensorsPoint-of-care Diagnostic DevicesRaman SpectroscopyAcute Coronary Syndrome DetectionCardiovascular Biomarker DetectionNanoparticle-based BiosensorsNanoparticlesPoint-of-care NanobiosensorsSensingSurface-enhanced Raman Scattering BiosensingSurface-enhanced Raman Scattering Biosensors
According to the World Health Organization, cardiovascular disease is the most common cause of death in the world. In the US, over 115 million people visit the emergency department (ED), 5 million of which may have acute coronary syndrome (ACS). Cardiac biomarkers can provide early identification and diagnosis of ACS, and can provide information on the prognosis of the patient by assessing the risk of death. In addition, the biomarkers can serve as criteria for admission, indicate possibility of re-infarction, or eliminate ACS as a diagnosis altogether. We propose a SERSbased multi-marker approach towards a point-of-care diagnostic system for ACS. Using a nanofluidic device consisting of a microchannel leading into a nanochannel, we formed SERS active sites by mechanically aggregating gold particles (60 nm) at the entrance to the nanochannel (40nm×1μm). The induced capillary flow produces a high density of aggregated nanoparticles at this precise region, creating areas with enhanced electromagnetic fields within the aggregates, shifting the plasmon resonance to the near infrared region, in resonance with incident laser wavelength. With this robust sensing platform, we were able to obtain qualitative information of brain natriuretic peptide (biomarker of ventricular dysfunction or pulmonary stress), troponin I (biomarker of myocardial necrosis), and C-reactive protein (biomarker of inflammation potentially caused by atherosclerosis).
11
B-type natriuretic peptide in cardiovascular disease
James A. de Lemos, Darren K. McGuire, Mark H. Drazner · The Lancet · 2003 · 1.1K citations
Damien Logeart, Gabriel Thabut, Patrick Jourdain et al. · Journal of the American College of Cardiology · 2004 · 591 citations